Showing 1 - 20 results of 81,172 for search '(( 59 ((_ decrease) OR (a decrease)) ) OR ((( _ e decrease ) OR ( 10 min decrease ))))*', query time: 0.96s Refine Results
  1. 1
  2. 2
  3. 3

    Anesthetics differentially decrease cilia-driven particle transport speed (PTS). by Ghulam Murtaza (2559319)

    Published 2016
    “…<b>(D)</b> Avertin® (1 mM) decreased PTS. N = 5 tracheas from 5 animals. <b>(E)</b> Avertin® (4 mM) robustly decreased basal PTS and ATP could not induce increase in PTS. …”
  4. 4
  5. 5
  6. 6
  7. 7

    Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats-0 by Jean-Louis Gallis (2926)

    Published 2011
    “…The reference (methylene-diphosphonic acid) is not shown (18.40 ppm) (number of scans = 148). B: 20 min after a perfusion of butyrate 3 mmol/L, effect (from the bottom to the top) of the simultaneous addition of IAA 0.5 mmol/L (2 min) and KCN 2.5 mmol/L (10 min) (number of scans = 60).…”
  8. 8
  9. 9

    <i>B-MOBILE</i> - A Smartphone-Based Intervention to Reduce Sedentary Time in Overweight/Obese Individuals: A Within-Subjects Experimental Trial by Dale S. Bond (588506)

    Published 2014
    “…Average % SED at baseline (72.2%) decreased by 5.9%, 5.6%, and 3.3% [i.e. by mean (95% CI) −47.2(−66.3, −28.2), −44.5(−65.2, −23.8), and −26.2(−40.7, −11.6) min/d] in the 3-, 6-, and 12-min conditions, respectively. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice. by Jun Yu (5904)

    Published 2012
    “…(E) PDGF-BB receptor tyrosine kinase inhibitor decreases immunoreactive survivin levels in LC of eNOS (−/−) mice, compared to vehicle treated eNOS (−/−) mice (left panel). …”
  19. 19

    Supplementary Material for: Kidney and cardiovascular outcomes in older population with mildly to moderately decreased kidney function - A nationwide cohort study by Jeon J. (10323467)

    Published 2024
    “…We investigated the clinical outcomes in older populations with mildly to moderately decreased GFR (45–59 ml/min/1.73 m2, CKD stage 3A). …”
  20. 20